Cessation of anti-VLA-4 therapy in a focal rat model of multiple sclerosis causes an increase in neuroinflammation

TSPO tracer [F-18]GE-180 reveals the effect of anti-VLA-4 mAb therapy on brain inflammation in the rat model of multiple sclerosis. https://t.co/Gb5RoIAJSW

RT @GavinGiovannoni: Rebound, rebound, rebound ..... Reverse translation; finally the animal studies catch-up with the clinic. I wonder if…

#MSlife 🇬🇧

RT @GavinGiovannoni: Rebound, rebound, rebound ..... Reverse translation; finally the animal studies catch-up with the clinic. I wonder if…

Rebound, rebound, rebound ..... Reverse translation; finally the animal studies catch-up with the clinic. I wonder if Biogen will now accept rebound post-natalizumab as a real clinical entity? #ResearchSpeak https://t.co/RVMvYfAbhc https://t.co/octx1zbbJG